Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 300

1.

No pain, no gain: lack of exercise obstructs neurogenesis.

Watson N, Ji X, Yasuhara T, Date I, Kaneko Y, Tajiri N, Borlongan CV.

Cell Transplant. 2015;24(4):591-7. doi: 10.3727/096368915X687723. Epub 2015 Mar 24.

PMID:
25806858
2.

Prediction model for 3-year rupture risk of unruptured cerebral aneurysms in Japanese patients.

Tominari S, Morita A, Ishibashi T, Yamazaki T, Takao H, Murayama Y, Sonobe M, Yonekura M, Saito N, Shiokawa Y, Date I, Tominaga T, Nozaki K, Houkin K, Miyamoto S, Kirino T, Hashi K, Nakayama T; Unruptured Cerebral Aneurysm Study Japan Investigators.

Ann Neurol. 2015 Mar 6. doi: 10.1002/ana.24400. [Epub ahead of print]

PMID:
25753954
3.

Regenerative medicine for Parkinson's disease.

Yasuhara T, Kameda M, Agari T, Date I.

Neurol Med Chir (Tokyo). 2015;55(2):113-23. doi: 10.2176/nmc.ra.2014-0264. Epub 2015 Jan 23.

4.

Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma.

Onishi M, Ichikawa T, Kurozumi K, Inoue S, Maruo T, Otani Y, Fujii K, Ishida J, Shimazu Y, Yoshida K, Michiue H, Antonio Chiocca E, Date I.

Brain Tumor Pathol. 2015 Feb 20. [Epub ahead of print]

PMID:
25697644
5.

Evaluation of prostaglandin e2 and e-series prostaglandin receptor in patients with interstitial cystitis.

Wada N, Ameda K, Furuno T, Okada H, Date I, Kakizaki H.

J Urol. 2015 Jun;193(6):1987-93. doi: 10.1016/j.juro.2015.01.010. Epub 2015 Jan 13.

PMID:
25595860
6.

[Cervical spinal dural arteriovenous fistula with rapidly progressive brainstem dysfunction due to venous congestion: a case report].

Sasaki T, Manabe H, Yasuhara T, Miyoshi Y, Sugiu K, Date I.

No Shinkei Geka. 2015 Jan;43(1):51-6. doi: 10.11477/mf.1436202944. Japanese.

PMID:
25557099
7.

Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma.

Ichikawa T, Kurozumi K, Michiue H, Ishida J, Maeda Y, Kondo E, Kawasaki A, Date I.

Clin Neurol Neurosurg. 2014 Dec;127:106-11. doi: 10.1016/j.clineuro.2014.10.011. Epub 2014 Oct 22.

PMID:
25459253
8.

Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.

Shimazu Y, Kurozumi K, Ichikawa T, Fujii K, Onishi M, Ishida J, Oka T, Watanabe M, Nasu Y, Kumon H, Date I.

Gene Ther. 2015 Feb;22(2):146-54. doi: 10.1038/gt.2014.100. Epub 2014 Nov 13.

PMID:
25394252
9.

[The use of the ubiquitin-proteasome system in neurosurgery and the clinical applications of protein therapy].

Michiue H, Date I.

No Shinkei Geka. 2014 Oct;42(10):899-906. doi: 10.11477/mf.1436200003. Review. Japanese. No abstract available.

PMID:
25266580
10.

Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke.

Tajiri N, Acosta S, Portillo-Gonzales GS, Aguirre D, Reyes S, Lozano D, Pabon M, Dela Peña I, Ji X, Yasuhara T, Date I, Solomita MA, Antonucci I, Stuppia L, Kaneko Y, Borlongan CV.

Front Cell Neurosci. 2014 Aug 13;8:227. doi: 10.3389/fncel.2014.00227. eCollection 2014. Review.

11.

Spinal cord stimulation exerts neuroprotective effects against experimental Parkinson's disease.

Shinko A, Agari T, Kameda M, Yasuhara T, Kondo A, Tayra JT, Sato K, Sasaki T, Sasada S, Takeuchi H, Wakamori T, Borlongan CV, Date I.

PLoS One. 2014 Jul 10;9(7):e101468. doi: 10.1371/journal.pone.0101468. eCollection 2014.

12.

Combined Transarterial and Transvenous Approach for Curative Obliteration of Klippel-Trenaunay-Weber Syndrome-Associated Spinal Perimedullary Arteriovenous Fistulas.

Tokunaga K, Hishikawa T, Sugiu K, Date I.

Clin Neuroradiol. 2014 Jul 10. [Epub ahead of print] No abstract available.

PMID:
25008156
13.

[Anti-high mobility group box-1 antibody therapy for traumatic brain injury].

Okuma Y, Date I, Nishibori M.

Yakugaku Zasshi. 2014;134(6):701-5. Review. Japanese.

14.

Long-term outcomes in adult patients with ischemic-type moyamoya disease involving posterior circulation.

Hishikawa T, Tokunaga K, Sugiu K, Date I.

Acta Neurochir (Wien). 2014 Sep;156(9):1745-51. doi: 10.1007/s00701-014-2136-3. Epub 2014 May 28.

PMID:
24866473
15.

Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction.

Okuma Y, Liu K, Wake H, Liu R, Nishimura Y, Hui Z, Teshigawara K, Haruma J, Yamamoto Y, Yamamoto H, Date I, Takahashi HK, Mori S, Nishibori M.

Neuropharmacology. 2014 Oct;85:18-26. doi: 10.1016/j.neuropharm.2014.05.007. Epub 2014 May 20.

PMID:
24859607
16.

Cerebral vasospasm in patients over 80 years treated by coil embolization for ruptured cerebral aneurysms.

Hishikawa T, Takasugi Y, Shimizu T, Haruma J, Hiramatsu M, Tokunaga K, Sugiu K, Date I.

Biomed Res Int. 2014;2014:253867. doi: 10.1155/2014/253867. Epub 2014 Mar 24.

17.

Integrin inhibitor suppresses bevacizumab-induced glioma invasion.

Ishida J, Onishi M, Kurozumi K, Ichikawa T, Fujii K, Shimazu Y, Oka T, Date I.

Transl Oncol. 2014 Apr;7(2):292-302.e1. doi: 10.1016/j.tranon.2014.02.016. Epub 2014 Mar 4.

18.

Fatal glioblastoma after Gamma Knife radiosurgery for arteriovenous malformation in a child.

Yoshida K, Ichikawa T, Kurozumi K, Yanai H, Onoda K, Date I.

J Clin Neurosci. 2014 Aug;21(8):1453-5. doi: 10.1016/j.jocn.2013.10.039. Epub 2014 Feb 7.

PMID:
24613764
19.

Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.

Wakamori T, Agari T, Yasuhara T, Kameda M, Kondo A, Shinko A, Sasada S, Sasaki T, Furuta T, Date I.

Parkinsonism Relat Disord. 2014 Apr;20(4):415-20. doi: 10.1016/j.parkreldis.2014.01.002. Epub 2014 Jan 13.

PMID:
24467818
20.

[Anti-HMGB1 antibody therapy for traumatic brain injury and neuropathic pain].

Okuma Y, Date I, Nishibori M.

Nihon Yakurigaku Zasshi. 2014 Jan;143(1):5-9. Review. Japanese. No abstract available.

PMID:
24420129
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk